January 31, 2024 · Form 4 insider transaction
Rebel Vivienne I bought 31,847 shares of bioAffinity Technologies, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024.